Tsuyoshi Morita
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'.
Journal: Japanese journal of clinical oncology
Published: March 02, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.
Journal: Japanese journal of clinical oncology
Published: November 20, 2025
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.
Journal: Japanese journal of clinical oncology
Published: November 08, 2025
A novel prohibitin inhibitor acts as a dual inhibitor of angiogenesis and fibrosis.
Journal: Biochemical and biophysical research communications
Published: October 15, 2025
PYGL-driven glycogenolysis impairs microglial autophagic flux via SNAP29 O-GlcNAcylation in Alzheimer's disease.
Journal: Acta pharmaceutica Sinica. B
Published: September 02, 2025
Glycogen and lactate metabolism in mouse fetal Sertoli cells sustain the germ line.
Journal: Cell reports
Published: September 01, 2025
Glycogen metabolism in mouse embryonic Sertoli cells sustains the germ line through the lactate shuttle.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.
Journal: Japanese journal of clinical oncology
Published: July 28, 2025
Distribution and functional significance of rodent cerebellar glycogen.
Journal: iScience
Published: July 09, 2025
Last Updated: 09/26/2026